Publikationen, an denen er mitarbeitet Antoni Torres Martí (79)

2024

  1. At-admission prediction of mortality and pulmonary embolism in an international cohort of hospitalised patients with COVID-19 using statistical and machine learning methods

    Scientific Reports, Vol. 14, Núm. 1

  2. Basic host response parameters to classify mortality risk in COVID-19 and community-acquired pneumonia

    Scientific reports, Vol. 14, Núm. 1, pp. 12726

  3. Cost-Sensitive Ordinal Classification Methods to Predict SARS-CoV-2 Pneumonia Severity

    IEEE Journal of Biomedical and Health Informatics, Vol. 28, Núm. 5, pp. 2613-2623

  4. Global mortality and readmission rates following COPD exacerbation-related hospitalisation: a meta-analysis of 65 945 individual patients

    ERJ Open Research, Vol. 10, Núm. 1

  5. Optimising Clinical Epidemiology in Disease Outbreaks: Analysis of ISARIC-WHO COVID-19 Case Report Form Utilisation

    Epidemiologia, Vol. 5, Núm. 3, pp. 557-580

2023

  1. Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19

    International Journal of Epidemiology, Vol. 52, Núm. 2, pp. 355-376

  2. Extracting relevant predictive variables for COVID-19 severity prognosis: An exhaustive comparison of feature selection techniques

    PLoS ONE, Vol. 18, Núm. 4 April

  3. Impact of outdoor air pollution on severity and mortality in COVID-19 pneumonia

    Science of the Total Environment, Vol. 894

  4. Is the long-term mortality similar in COVID-19 and community-acquired pneumonia?

    Frontiers in Medicine, Vol. 10

  5. Key Factors Associated With Pulmonary Sequelae in the Follow-Up of Critically Ill COVID-19 Patients

    Archivos de Bronconeumologia, Vol. 59, Núm. 4, pp. 205-215

  6. Persistent Respiratory Failure and Re-Admission in Patients with Chronic Obstructive Pulmonary Disease Following Hospitalization for COVID-19

    International Journal of COPD, Vol. 18, pp. 2473-2481

  7. Pneumococcal Serotypes Associated with Community-Acquired Pneumonia Hospitalizations in Adults in Spain, 2016–2020: The CAPA Study

    Microorganisms, Vol. 11, Núm. 11

  8. Validation of IDSA/ATS Guidelines for ICU Admission in Adults Over 80 Years Old With Community-Acquired Pneumonia

    Archivos de Bronconeumologia, Vol. 59, Núm. 1, pp. 19-26

2022

  1. COVID-19 in young and middle-aged adults: predictors of poor outcome and clinical differences

    Infection, Vol. 50, Núm. 1, pp. 179-189

  2. Early Recognition of Low-Risk SARS-CoV-2 Pneumonia: A Model Validated With Initial Data and Infectious Diseases Society of America/American Thoracic Society Minor Criteria

    Chest, Vol. 162, Núm. 4, pp. 768-781

  3. Early procalcitonin to predict mortality in critically ill COVID-19 patients: a multicentric cohort study

    Minerva Anestesiologica, Vol. 88, Núm. 4, pp. 259-271

  4. Estimating the risk of bacteraemia in hospitalised patients with pneumococcal pneumonia

    Journal of Infection, Vol. 85, Núm. 6, pp. 644-651

  5. ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19

    Scientific Data, Vol. 9, Núm. 1

  6. Prognostic implications of comorbidity patterns in critically ill COVID-19 patients: A multicenter, observational study

    The Lancet Regional Health - Europe, Vol. 18

2021

  1. Aspiration Risk Factors, Microbiology, and Empiric Antibiotics for Patients Hospitalized With Community-Acquired Pneumonia

    Chest, Vol. 159, Núm. 1, pp. 58-72